Related Experiment Video
Updated: May 13, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Diffuse glioneuronal tumor in Lynch syndrome: illustrative case
Stephen Jaffee1, Trent Kite1, Kymberly Gyure2
1Department of Neurosurgery, Allegheny Health Network Neuroscience Institute, Pittsburgh, Pennsylvania.
Lynch syndrome (LS) patients may develop aggressive glioneuronal tumors. This case highlights a rare LS-associated glioneuronal tumor with rapid progression, suggesting a worse prognosis than typical glioneuronal tumors.
Area of Science:
- Neuro-oncology
- Genetics
- Cancer Biology
Background:
- Lynch syndrome (LS) is an inherited disorder linked to DNA mismatch repair defects.
- LS increases the risk of various cancers, including brain tumors like oligodendrogliomas and astrocytomas.
- This report details a unique case of LS with a glioneuronal tumor exhibiting both glial and neuronal differentiation.
Purpose of the Study:
- To report a rare case of a glioneuronal tumor in a patient with Lynch syndrome.
- To investigate the clinical behavior and prognosis of glioneuronal tumors associated with LS.
- To highlight the potential for aggressive tumor progression in this specific patient population.
Main Methods:
- Case presentation of a 34-year-old female with a frontal lobe mass.
- Surgical resection and histopathological examination of the tumor.
- Molecular testing for MSH2 mutation and germline testing for LS confirmation.
- Monitoring for tumor progression and assessment of proliferation markers (Ki-67).
Main Results:
- A low-grade-appearing glioneuronal tumor was diagnosed.
- The patient was confirmed to have Lynch syndrome due to an MSH2 mutation.
- Tumor progression occurred 12 months post-surgery, with a significant increase in Ki-67 proliferation index.
- Adjuvant therapy with temozolomide and radiation was initiated.
Conclusions:
- Glioneuronal tumors in the context of Lynch syndrome may exhibit a more aggressive clinical course.
- This case suggests a potentially worse prognosis for LS-associated glioneuronal tumors compared to typical cases.
- Further research is warranted to understand the implications of LS on brain tumor behavior.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021